Learn why the FDA is asking to update testosterone replacement therapy labels after a major review of new evidence.

Second, the changes would ease longstanding warnings about the use of the hormone therapy in those with prostate cancer. Current labels say testosterone should not be used in men ...

The US Department of Health and Human Services is requesting revisions to the labels on testosterone replacement therapies for men after reviewing new data and evidence on their safety and benefits.

Most men assume that if their testosterone is low, they can get treatment. But since 2015, FDA labeling has included cautionary language noting that the safety and effectiveness of testosterone ...

Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...

June 18 (Reuters) - The U.S. health department said on Thursday it was seeking updates to labels for testosterone replacement therapies after reviewing new clinical data and other evidence. The ...

The US government wants testosterone replacement therapy labels updated to reflect newer research on heart health and prostate cancer, but doctors stress that treatment should still be reserved for ...

Drs Chris and Xand ask - what are the pros and cons of testosterone replacement therapy?

Testosterone replacement therapy does not improve glycemic control in men with hypogonadism. Although low testosterone levels are associated with increased risks for prediabetes and type 2 diabetes in ...

With this in mind, it seems natural that using testosterone replacement therapy (TRT) for weight loss purposes could be a potential solution. But while it’s been marketed for this, experts caution ...

The use of metformin and testosterone replacement therapy, either individually or in combination, is associated with significant reductions in the incidence of prostate and colorectal cancer in men ...

Something keeps happening to men’s hormones. Across nearly 50 years and five countries, testosterone levels have fallen ...